Pefloxacin mesylate is a pharmaceutical substance used as an antibiotic medication in the fluoroquinolone class. It is derived from the generic drug pefloxacin, which is an antibiotic used to treat bacterial infections. Pefloxacin mesylate is the mesylate salt form of pefloxacin.
As an antibiotic, pefloxacin mesylate works by inhibiting the growth and replication of bacteria. It achieves this by interfering with the enzymes necessary for bacterial DNA replication, thus preventing the bacteria from multiplying and causing an infection.
Pefloxacin mesylate is primarily prescribed to treat various types of bacterial infections, including urinary tract infections, respiratory tract infections, genital infections, gastrointestinal infections, and skin infections. It is effective against both Gram-positive and Gram-negative bacteria, including strains resistant to other antibiotics.
It is typically administered orally in tablet form or as an intravenous infusion, depending on the severity of the infection. The dosage and treatment duration are determined by the prescribing doctor, taking into consideration the patient's medical condition, age, and other factors.
Like other medications, pefloxacin mesylate may have potential side effects, including nausea, vomiting, diarrhea, dizziness, headache, and skin rashes. It may also cause more serious adverse reactions such as tendonitis, tendon rupture, and allergic reactions in rare cases.
Overall, pefloxacin mesylate is an antimicrobial agent that effectively treats bacterial infections by inhibiting bacterial DNA replication. Its effectiveness, dosage, and potential side effects should be carefully considered by medical professionals to ensure safe and effective treatment for patients.
